Unexplained weight loss

See Doctor Soon

3 studies · 1 recommendation

Last updated: February 25, 2026

Unexplained weight loss – Colorectal Cancer
See Doctor Soon3 studies

Unexplained weight loss signals higher mortality risk and demands prompt medical evaluation

Across 3 studies including a meta-analysis of 124 observational studies, unexplained weight loss in colorectal cancer patients consistently predicted worse outcomes. Post-diagnosis BMI of 18 kg/m² carried 60% higher all-cause mortality, 95% higher colorectal cancer-specific mortality, and 37% higher cancer recurrence risk compared to BMI 28 kg/m². In a study of 388 patients, cancer anorexia-cachexia syndrome was highly prevalent and significantly impacted morbidity and mortality. Early detection through nutritional screening enabled interventions that temporarily halted weight loss, with a median weight gain of 1.5 kg. Any unexplained weight loss warrants prompt clinical assessment to rule out disease progression and initiate nutritional support before functional decline occurs.

Evidence

Authors: Aune, Dagfinn, Balducci, Katia, Baskin, Monica L., Becerra‐Tomás, Nerea, Bours, Martijn, Cariolou, Margarita, Chowdhury, Rajiv, Copson, Ellen, Demark‐Wahnefried, Wendy, Dossus, Laure, Greenwood, Darren C., Hill, Lynette, Hudson, Melissa M., Kiss, Sonia, Krebs, John, Lewis, Sarah J., Markozannes, Georgios, May, Anne M., Odedina, Folakemi T., Renehan, Andrew G., Skinner, Roderick, Steindorf, Karen, Tjønneland, Anne, Velikova, Galina, Vieira, Rita

Published: May 1, 2024

In the meta-analysis of 124 observational studies, post-diagnosis BMI of 18 kg/m² compared to the nadir of 28 kg/m² was associated with 60% higher all-cause mortality, 95% higher colorectal cancer-specific mortality, and 37% higher cancer recurrence risk. The elevated risk at low BMI was attenuated in secondary analyses of RCTs compared to cohort studies and among studies with longer follow-up, suggesting low BMI partly reflects reverse causation from advanced disease rather than an independent causal factor.

Authors: Aune D, Balducci K, Baskin ML, Becerra-Tomas N, Bours M, Cariolou M, Chan DSM, Chowdhury R, Copson E, Cross AJ, Demark-Wahnefried W, Dossus L, Greenwood DC, Hill L, Hudson MM, Kiss S, Krebs J, Lewis SJ, Markozannes G, May AM, Odedina FT, Renehan AG, Seidell J, Skinner R, Steindorf K, Tjonneland A, Tsilidis KK, Velikova G, Vieira R, Weijenberg MP

Published: January 1, 2024

Meta-analysis of 124 observational studies found that low post-diagnosis BMI (18 kg/m²) carried the highest relative risk across all colorectal cancer outcomes compared to the nadir at BMI 28 kg/m²: 60% increased all-cause mortality, 95% increased colorectal cancer-specific mortality, and 37% increased cancer recurrence or reduced disease-free survival. The elevated risk at the low BMI end was attenuated in secondary analyses of RCTs compared to cohort studies, in studies with longer follow-up, and among women, suggesting that reverse causation from disease progression may partially explain the association.

Authors: Dragan Trivanović, Jelena Vukelic, Marijan Dintinjana, Nenad Vanis, Renata Dobrila-Dintinjana

Published: February 17, 2012

Among 388 colorectal cancer patients in a non-randomized interventional study, cancer anorexia-cachexia syndrome was identified as highly prevalent with significant impact on morbidity and mortality. When 215 patients received early nutritional support and monitoring using the Nottingham Screening Tool Questionnaire and Appetite Loss Scale, weight loss was temporarily halted with a median weight gain of 1.5 kg (range 0.6–2.8 kg) and appetite improved. These findings demonstrate that early detection of weight loss allows interventions that preserve nutritional status, though Karnofsky Performance Status remained unchanged in both groups.